Skip to content

Uptake and Utilization of Amino Acids by Splanchnic Bed

Determination of the Difference in Uptake and Utilization of Two Amino Acids by the Splanchnic Bed

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01032616
Enrollment
6
Registered
2009-12-15
Start date
2009-12-31
Completion date
2010-08-31
Last updated
2013-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Males

Keywords

splanchnic bed, theronine and lysine metabolism uptake, isotopes, metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed by Healthy Males

Brief summary

Splanchnic uptake and metabolism contributes significantly to the differences in flux seen between the intravenous and intragastric ingestion of certain indispensable amino acids. This is the third in a series of studies designed to increase the investigators knowledge of the metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed. In the initial two studies the investigators established the neonatal parenteral requirement of threonine and lysine. In the current study, the investigators will be examining the differences in uptake and metabolism of threonine and lysine across the splanchnic bed.

Detailed description

We propose that we will see a smaller amount of enterally fed isotopes reach the plasma as compared to the amount in plasma from the parenterally delivered isotopes. We also believe that the amount of enterally delivered threonine isotope that reaches the plasma will be significantly less than the amount of enterally fed lysine isotope.

Interventions

OTHERThreonine Experimental: Study Period 1

Enteral and parenteral infusion of threonine isotope

OTHERLysine Experimental: Study Period 2

Both intravenous (iv) and intragastric (ig) Lysine isotopes.

Sponsors

The Hospital for Sick Children
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy Males

Exclusion criteria

* History of inborn error of metabolism * Presence of a chronic disease * Have unusual dietary practices * Has recently lost weight * Receiving pharmacological therapy or hormonal treatment

Design outcomes

Primary

MeasureTime frame
Breath VCO2-30min, -20min, -10min, +2.5hrs, +3 hrs, +3.5hrs, +4hrs,+4.5hrs, +5hrs
Blood CO2-30min, -20min, -10min, +2.5hrs, +3 hrs, +3.5hrs, +4hrs,+4.5hrs, +5hrs

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026